Arizona's $34.8 Million: What the SOR IV Grant Can—and Can't—Fix

When Kennedy announced more than $700 million in behavioral health funding on June 17, the rollout included language about addressing addiction and getting people into treatment across the country. Arizona providers, accustomed to watching federal announcements carefully for what actually lands in the state, had reason to look past the headline.

The relevant Arizona number is not $700 million. It’s $34.8 million.

That is the year-one award Arizona received in September 2024 for the State Opioid Response IV (SOR IV) grant—a three-year, renewable SAMHSA program administered through AHCCCS, the state’s Medicaid agency. The grant’s overarching goal is specific: increase access to opioid use disorder treatment, expand medication-assisted treatment (MAT) through provider education and stigma reduction, and establish 24/7 care access points across the state. Stimulant use disorder—primarily methamphetamine—is included explicitly, reflecting the reality that Arizona’s crisis is polysubstance.

The grant is real, meaningful, and now in the middle of its implementation phase. It is not new. And it exists in the context of the most damning statistic in Arizona’s behavioral health landscape: the state ranks 49th out of 51 for behavioral health access. Fewer than one in twenty Arizonans with opioid use disorder receive medications like buprenorphine or methadone. For a state where more than five people die from opioid overdoses every day and where fentanyl is implicated in 65% of overdose deaths, the gap between need and access is not small.

What SOR IV funds can address: more prescribers trained and willing to provide buprenorphine, more outreach to the communities furthest from care (rural northern Arizona, rural border counties, tribal lands where overdose rates have been rising), more peer support specialists embedded in emergency departments and detox programs. These are real interventions that reduce overdose death when implemented consistently.

What $34.8 million cannot address: the structural shortage of behavioral health workforce in a state that has chronically underpaid and undersupported mental health and addiction treatment workers. The insurance reimbursement rates that make MAT economically marginal for many primary care providers. The transportation and housing barriers that prevent people in Kingman or Show Low from accessing treatment in Flagstaff or Phoenix even when they want to go.

Kennedy’s STREETS program, with its housing and harm reduction restrictions, will not help with those structural barriers either—and even if it does fund Arizona communities, the exclusion of Housing First approaches is a particular problem in a state where housing instability is one of the primary drivers of treatment dropout.

AHCCCS intends to submit continuation applications for SOR IV years two and three. The clinical access expansion work is ongoing. What Arizona’s providers need from the federal government is not another announcement—it is the workforce, reimbursement, and resource infrastructure that the advocacy community has been requesting for years. The SOR IV grant is a tool. It is not enough of one.

---

Rize Recovery is built specifically for Arizona’s treatment landscape—find opioid and stimulant treatment near you or browse our Arizona coverage for ongoing tracking of state policy and resources.